Samsara BioCapital as of June 30, 2023
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 47 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chinook Therapeutics | 34.8 | $198M | 5.2M | 38.42 | |
| Mineralys Therapeutics (MLYS) | 13.5 | $77M | 4.5M | 17.05 | |
| Acelyrin | 8.3 | $47M | 2.3M | 20.90 | |
| Scholar Rock Hldg Corp (SRRK) | 6.1 | $35M | 4.6M | 7.54 | |
| Graphite Bio | 3.9 | $22M | 8.5M | 2.60 | |
| Arcellx Common Stock (ACLX) | 3.4 | $19M | 614k | 31.62 | |
| Avadel Pharmaceuticals Sponsored Adr | 2.8 | $16M | 968k | 16.48 | |
| Zymeworks Del (ZYME) | 2.2 | $13M | 1.5M | 8.64 | |
| Iveric Bio | 2.1 | $12M | 308k | 39.34 | |
| Lyra Therapeutics | 2.0 | $11M | 2.8M | 4.11 | |
| Hillevax | 1.8 | $10M | 599k | 17.19 | |
| Dice Therapeutics | 1.7 | $9.4M | 203k | 46.46 | |
| Sutro Biopharma (STRO) | 1.4 | $7.8M | 1.7M | 4.65 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.3 | $7.3M | 348k | 21.14 | |
| Aclaris Therapeutics (ACRS) | 1.3 | $7.2M | 696k | 10.37 | |
| Intercept Pharmaceuticals In | 1.2 | $7.1M | 641k | 11.06 | |
| Prime Medicine (PRME) | 1.2 | $6.9M | 470k | 14.65 | |
| Nkarta (NKTX) | 1.1 | $6.3M | 2.9M | 2.19 | |
| Pepgen (PEPG) | 1.0 | $5.8M | 651k | 8.94 | |
| Rhythm Pharmaceuticals (RYTM) | 1.0 | $5.7M | 345k | 16.49 | |
| Immunocore Hldgs Ads (IMCR) | 0.9 | $4.9M | 81k | 59.96 | |
| Immatics SHS (IMTX) | 0.8 | $4.6M | 396k | 11.54 | |
| Janux Therapeutics (JANX) | 0.8 | $4.3M | 360k | 11.87 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.7 | $3.8M | 432k | 8.70 | |
| Decibel Therapeutics | 0.5 | $3.1M | 802k | 3.85 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.5 | $2.8M | 882k | 3.15 | |
| Rain Therapeutics | 0.4 | $2.4M | 2.0M | 1.20 | |
| Day One Biopharmaceuticals I (DAWN) | 0.4 | $2.3M | 196k | 11.94 | |
| Tango Therapeutics (TNGX) | 0.4 | $2.1M | 630k | 3.32 | |
| Io Biotech (IOBT) | 0.3 | $2.0M | 1.0M | 1.96 | |
| Leap Therapeutics Com New (LPTX) | 0.3 | $1.9M | 602k | 3.13 | |
| Terns Pharmaceuticals (TERN) | 0.3 | $1.8M | 202k | 8.75 | |
| Igm Biosciences (IGMS) | 0.3 | $1.4M | 155k | 9.23 | |
| Bolt Biotherapeutics | 0.2 | $1.3M | 1.0M | 1.28 | |
| Elevation Oncology (ELEV) | 0.2 | $1.3M | 831k | 1.52 | |
| Vtv Therapeutics Cl A | 0.2 | $1.2M | 1.6M | 0.74 | |
| Instil Bio | 0.2 | $985k | 1.8M | 0.55 | |
| Viracta Therapeutics (VIRX) | 0.2 | $973k | 690k | 1.41 | |
| Allakos | 0.1 | $750k | 172k | 4.36 | |
| Aeglea Biotherapeutics | 0.1 | $398k | 884k | 0.45 | |
| Allovir (ALVR) | 0.0 | $280k | 82k | 3.40 | |
| Astria Therapeutics (ATXS) | 0.0 | $208k | 25k | 8.33 | |
| Science 37 Holdings | 0.0 | $191k | 900k | 0.21 | |
| Novavax Com New (NVAX) | 0.0 | $158k | 21k | 7.43 | |
| Kronos Bio | 0.0 | $134k | 78k | 1.72 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $22k | 133k | 0.17 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $5.5k | 100k | 0.06 |
